PACB position history
The shares of Pacific Biosciences Calif (PACB) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 1,992,250 shares, $51M, 0.26% of portfolio
- 2021 Q4: 2,045,488 shares, $42M, 0.22% of portfolio, Add +2.7%
- 2022 Q1: 1,631,800 shares, $15M, 0.08% of portfolio, Reduce −20.2%
- 2022 Q2: not held, Exit
- 2022 Q3: not held
- 2022 Q4: 4,004,400 shares, $33M, 0.21% of portfolio, New
- 2023 Q1: 6,355,120 shares, $74M, 0.42% of portfolio, Add +58.7%
- 2023 Q2: 8,338,120 shares, $111M, 0.62% of portfolio, Add +31.2%
- 2023 Q3: 10,224,120 shares, $85M, 0.43% of portfolio, Add +22.6%
- 2023 Q4: 6,191,370 shares, $61M, 0.30% of portfolio, Reduce −39.4%
- 2024 Q1: 7,544,904 shares, $28M, 0.13% of portfolio, Add +21.9%
- 2024 Q2: 135,000 shares, $185K, <0.01% of portfolio, Reduce −98.2%
- 2024 Q3: 135,000 shares, $230K, <0.01% of portfolio
- 2024 Q4: 135,000 shares, $247K, <0.01% of portfolio
- 2025 Q1: 135,000 shares, $159K, <0.01% of portfolio
- 2025 Q2: 135,000 shares, $167K, <0.01% of portfolio
- 2025 Q3: 270,000 shares, $346K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 135,000 shares, $252K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 135,000 shares, $178K, <0.01% of portfolio
- 2026 Q2: 14,200 shares, $24K, <0.01% of portfolio, Reduce −89.5%
- 2026 Q3: 14,200 shares, $34K, <0.01% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|